Medellin, Colombia: Pitfalls to Avoid When Entering the US Cannabinoid Product Market

There is so much that can go wrong when entering the US cannabinoid or supplement marketplace. In this session we discuss how to avoid common labeling, product manufacturing, registration, and marketing errors that can delay launches, or worse, attract the attention of the FDA and class action attorneys.

See pictures and the post on Asa's speech here.